相关实验视频
Updated: Jan 14, 2026
07:27
Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
25.1K
了解先天性心脏手术后的死亡率:程序特定因素增加了什么?
Meena Nathan1, Larry Han2, Katya Zelevinsky3
1Department of Cardiac Surgery, Boston Children's Hospital, Boston, Massachusetts; Department of Surgery, Harvard Medical School, Boston, Massachusetts.
The Annals of thoracic surgery
|October 23, 2025
概括
程序特异性因素 (PSFs) 改善了一些先天性心脏手术的手术死亡率模型. 并非所有PSF都具有同等的影响力,有助于改进风险评估并减少数据收集负担.
科学领域:
- 生产性心脏手术 手术 生产心脏手术
- 心血管外科心血管外科
- 医疗保健服务研究 医疗服务研究
背景情况:
- 胸腔外科医生协会先天性心脏手术数据库 (STS-CHSD) 收集数据,但预测死亡率的程序特定因素 (PSF) 的价值尚未研究.
- 本研究评估了PSFs对大队列预期死亡率的理解的贡献.
研究的目的:
- 评估程序特定因素 (PSF) 对操作死亡率歧视的影响.
- 确定哪些特定的PSF最显著地影响基准操作 (BMOs) 中的死亡率估计.
主要方法:
- 利用了来自美国115个中心 (2016-2022) 的数据,用于捕获PSF的基准操作 (BMOs).
- 使用先进的统计方法,将基线风险模型与包含PSF的模型进行比较.
- 分析了模型歧视和个别PSF的影响,由BMO分层.
主要成果:
- 在37282个BMO中,手术死亡率为2.6%.
- 模型歧视从0.088 (基线) 提高到0.095 (基线+PSF) 整体,在9个BMO中的5个中加强了歧视.
- 根据BMO,PSF的影响有所不同;诺伍德和骨干动脉修复保留了最多的PSF,而心室隔膜缺陷没有保留.
结论:
- 将PSF纳入预期死亡率模型增加了对某些BMO的歧视.
- 特定的PSF显著影响死亡率估计,而其他则没有.
- 这些发现可以减少数据收集负担,并完善先天性心脏手术的风险模型.
相关概念视频
01:28Cardiomyopathy VII: Pre and Post Operative Nursing Management
283
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
283
01:27Mitral Stenosis IV: Nursing Management
246
A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
246
01:29Cardiomyopathy V: Interprofessional Care
335
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
335
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
399
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
399
01:21Cardiac Catheterization II: Right Heart Catheterization
803
Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...
803